The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Adipocyte-Derived Hormone Leptin Is a Direct Regulator of Aldosterone Secretion, Which Promotes Endothelial Dysfunction and Cardiac Fibrosis
Abstract
BACKGROUND: In obesity, the excessive synthesis of aldosterone contributes to the development and progression of metabolic and cardiovascular dysfunctions. Obesity-induced hyperaldosteronism is independent of the known regulators of aldosterone secretion, but reliant on unidentified adipocyte-derived factors. We hypothesized that the adipokine leptin is a direct regulator of aldosterone synthase (CYP11B2) expression and aldosterone release and promotes cardiovascular dysfunction via aldosterone-dependent mechanisms. METHODS AND RESULTS: Immunostaining of human adrenal cross-sections and adrenocortical cells revealed that adrenocortical cells coexpress CYP11B2 and leptin receptors. Measurements of adrenal CYP11B2 expression and plasma aldosterone levels showed that increases in endogenous (obesity) or exogenous (infusion) leptin dose-dependently raised CYP11B2 expression and aldosterone without elevating plasma angiotensin II, potassium or corticosterone. Neither angiotensin II receptors blockade nor α and β adrenergic receptors inhibition blunted leptin-induced aldosterone secretion. Identical results were obtained in cultured adrenocortical cells. Enhanced leptin signaling elevated CYP11B2 expression and plasma aldosterone, whereas deficiency in leptin or leptin receptors blunted obesity-induced increases in CYP11B2 and aldosterone, ruling out a role for obesity per se. Leptin increased intracellular calcium, elevated calmodulin and calmodulin-kinase II expression, whereas calcium chelation blunted leptin-mediated increases in CYP11B2, in adrenocortical cells. Mineralocorticoid receptor blockade blunted leptin-induced endothelial dysfunction and increases in cardiac fibrotic markers. CONCLUSIONS: Leptin is a newly described regulator of aldosterone synthesis that acts directly on adrenal glomerulosa cells to increase CYP11B2 expression and enhance aldosterone production via calcium-dependent mechanisms. Furthermore, leptin-mediated aldosterone secretion contributes to cardiovascular disease by promoting endothelial dysfunction and the expression of profibrotic markers in the heart.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, leptin adversely affects calcium handling in cardiomyocytes so as to impair myocardial relaxation, stimulates the synthesis of collagen inducing cardiac fibrosis by increasing aldosterone secretion, and enhances the sodium tubular reabsorption [95,96,97].”
From Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes (2022) · cites this paper as [96]
Citations
Cites
PTP1B Regulates Leptin Signal Transduction In Vivo
Zabolotny, J. M., Bence, K. K., Stricker‐Krongrad, A., Haj, F. G., Wang, Y., Minokoshi, Y., Kim, Y., Elmquist, J. K., Tartaglia, L. A., Kahn, B. B., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00148-x · Cited by 818
Ozata, M., Ozdemir, I. C., & Licinio, J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.5999 · Cited by 739
Abel, E. D., Litwin, S. E., & Sweeney, G. (2008) · Physiological Reviews · doi:10.1152/physrev.00017.2007 · Cited by 736
Attenuation of Leptin Action and Regulation of Obesity by Protein Tyrosine Phosphatase 1B
Cheng, A., Uetani, N., Simoncic, P. D., Chaubey, V. P., Lee-Loy, A., McGlade, C. J., Kennedy, B. P., & Tremblay, M. L. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00149-1 · Cited by 545
Obesity-induced Hypertension: Role of Sympathetic Nervous System, Leptin, and Melanocortins
Hall, J. E., da Silva, A. A., do Carmo, J. M., Dubinion, J., Hamza, S., Munusamy, S., Smith, G., & Stec, D. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.113175 · Cited by 528
Control of aldosterone secretion: a model for convergence in cellular signaling pathways
SPÄT, A., & HUNYADY, L. (2004) · Physiological Reviews · doi:10.1152/physrev.00030.2003 · Cited by 494
Human adipocytes secrete mineralocorticoid-releasing factors
Ehrhart‐Bornstein, M., Lamounier‐Zepter, V., Schraven, A., Langenbach, J., Willenberg, H. S., Barthel, A., Hauner, H., McCann, S. M., Scherbaum, W. A., & Bornstein, S. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336140100 · Cited by 442
Briones, A. M., Nguyen Dinh Cat, A., Callera, G. E., Yogi, A., Burger, D., He, Y., Corrêa, J. W., Gagnon, A. M., Gomez-Sanchez, C. E., Gomez-Sanchez, E. P., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.190223 · Cited by 375
Sixteen years and counting: an update on leptin in energy balance
Gautron, L., & Elmquist, J. K. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45888 · Cited by 367
Sowers, J. R., Whaley-Connell, A., & Epstein, M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00005 · Cited by 351
Flagged first, then by citations
Research works printed but not linked: 2
- 10.1161/01.HYP.0000231338.41548.fc · DOI · Paper page
- 10.1161/01.HYP.0000253258.36141.c7 · DOI
Cited by
Sorted by citations
Packer, M. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.509 · Cited by 656
Sex-specific differences in hypertension and associated cardiovascular disease
Colafella, K. M. M., & Denton, K. M. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.189 · Cited by 505
Borlaug, B. A., Jensen, M. D., Kitzman, D. W., Lam, C. S. P., Obokata, M., & Rider, O. J. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvac120 · Cited by 450
Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease
Jia, G., & Sowers, J. R. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17981 · Cited by 493
Vanhoutte, P. M., Zhao, Y., Xu, A., & Leung, S. W. S. (2016) · Circulation Research · doi:10.1161/circresaha.116.306531 · Cited by 406
Diagnosis and treatment of primary aldosteronism
Reincke, M., Bancos, I., Mulatero, P., Scholl, U. I., Stowasser, M., & Williams, T. A. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00210-2 · Cited by 377
Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies
Liu, M., Abad, B. L. D. J., & Cheng, K. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.021 · Cited by 370
Packer, M. (2018) · Circulation · doi:10.1161/circulationaha.117.032474 · Cited by 263
Treatment of Resistant and Refractory Hypertension
Acelajado, M. C., Hughes, Z. H., Oparil, S., & Calhoun, D. A. (2019) · Circulation Research · doi:10.1161/circresaha.118.312156 · Cited by 226
Mao, R., Kurada, S. V., Gordon, I. O., Baker, M. E., Gandhi, N. S., McDonald, C., Coffey, J. C., & Rieder, F. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy331 · Cited by 204
Packer, M., Lam, C. S. P., Lund, L. H., Maurer, M. S., & Borlaug, B. A. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1902 · Cited by 185
The Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction
Packer, M. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.06.055 · Cited by 213
Lakkis, J. I., & Weir, M. R. (2018) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.07.005 · Cited by 191
Role of Leptin in Cardiovascular Diseases
Poetsch, M. S., Strano, A., & Guan, K. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00354 · Cited by 191
Obesity-Related Heart Failure With a Preserved Ejection Fraction
Packer, M., & Kitzman, D. W. (2018) · JACC: Heart Failure · doi:10.1016/j.jchf.2018.01.009 · Cited by 172
Huby, A.-C., Otvos, L. J., & de Chantemèle, E. J. B. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06642 · Cited by 168
The Role of Aldosterone in Obesity-Related Hypertension
Kawarazaki, W., & Fujita, T. (2016) · American Journal of Hypertension · doi:10.1093/ajh/hpw003 · Cited by 170
Schütten, M. T. J., Houben, A. J. H. M., de Leeuw, P. W., & Stehouwer, C. D. A. (2017) · Physiology · doi:10.1152/physiol.00037.2016 · Cited by 172
Stowasser, M., & Gordon, R. D. (2016) · Physiological Reviews · doi:10.1152/physrev.00026.2015 · Cited by 162
Association of metabolic syndrome and chronic kidney disease
Scurt, F. G., Ganz, M. J., Herzog, C., Bose, K., Mertens, P. R., & Chatzikyrkou, C. (2024) · Obesity Reviews · doi:10.1111/obr.13649 · Cited by 155
Hypertension in Obesity and the Impact of Weight Loss
Cohen, J. B. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0912-4 · Cited by 147
Obesity and cardiovascular disease in women
Manrique‐Acevedo, C., Chinnakotla, B., Padilla, J., Martinez‐Lemus, L. A., & Gozal, D. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0548-0 · Cited by 154
Sex Differences in Mechanisms of Hypertension Associated With Obesity
Faulkner, J., & de Chantemèle, E. J. B. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09980 · Cited by 138
Regional Adiposity and Heart Failure with Preserved Ejection Fraction
Rao, V. N., Fudim, M., Mentz, R. J., Michos, E. D., & Felker, G. M. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1956 · Cited by 131
Primary Aldosteronism: State-of-the-Art Review
Vaidya, A., Hundemer, G. L., Nanba, K., Parksook, W. W., & Brown, J. M. (2022) · American Journal of Hypertension · doi:10.1093/ajh/hpac079 · Cited by 135
Essential role of ICAM-1 in aldosterone-induced atherosclerosis
Marzolla, V., Armani, A., Mammi, C., Moss, M. E., Pagliarini, V., Pontecorvo, L., Antelmi, A., Fabbri, A., Rosano, G. M. C., Jaffe, I. Z., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.01.013 · Cited by 124
Sex hormones, aging and cardiometabolic syndrome
Faulkner, J., & de Chantemèle, E. J. B. (2019) · Biology of Sex Differences · doi:10.1186/s13293-019-0246-6 · Cited by 124
Hypertension as a Metabolic Disorder and the Novel Role of the Gut
Tanaka, M., & Itoh, H. (2019) · Current Hypertension Reports · doi:10.1007/s11906-019-0964-5 · Cited by 120
Packer, M. (2021) · JACC Heart Failure · doi:10.1016/j.jchf.2021.05.019 · Cited by 116
Obesity-induced cognitive impairment in older adults: a microvascular perspective
Balasubramanian, P., Kiss, T., Tarantini, S., Nyúl‐Tóth, Á., Ahire, C., Yabluchanskiy, A., Csípő, T., Lipécz, Á., Tabák, Á. G., Institóris, Á., et al. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00736.2020 · Cited by 116
Improving obesity and blood pressure
Tanaka, M. (2019) · Hypertension Research · doi:10.1038/s41440-019-0348-x · Cited by 113
Packer, M. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015343 · Cited by 110
Mesenchymal stem cells in fibrotic diseases—the two sides of the same coin
Qin, L., Liu, N., Bao, C.-L.-M., Yang, D.-Z., Ma, G.-X., Yi, W.-H., Xiao, G.-Z., & Cao, H.-L. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00952-0 · Cited by 114
Epstein, M., Kovesdy, C. P., Clase, C. M., Sood, M. M., & Pecoits‐Filho, R. (2022) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2022.04.016 · Cited by 121
Liu, J., Yang, X., Yu, S., & Zheng, R. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1286-1_8 · Cited by 113
DuPont, J. J., & Jaffe, I. Z. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0009 · Cited by 107
Packer, M. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13229 · Cited by 105
Adipocytes, aldosterone and obesity-related hypertension
Cat, A. N. D., Friederich‐Persson, M., White, A. D., & Touyz, R. M. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0025 · Cited by 94
Hill, M. A., Jaisser, F., & Sowers, J. R. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa326 · Cited by 91
Biomarkers to Guide Medical Therapy in Primary Aldosteronism
Hundemer, G. L., Leung, A. A. C., Kline, G. A., Brown, J. M., Turcu, A. F., & Vaidya, A. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad024 · Cited by 92
Mechanisms and treatment of obesity-related hypertension—Part 1: Mechanisms
Parvanova, A. I., Reseghetti, E., Abbate, M., & Ruggenenti, P. L. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad282 · Cited by 104
Obesity and the kidney: mechanistic links and therapeutic advances
Yau, K., Kuah, R., Cherney, D. Z. I., & Lam, T. K. T. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-00951-7 · Cited by 91
Anti-Inflammatory Effects of Melatonin in Obesity and Hypertension
Prado, N. J., Ferder, L., Manucha, W. A., & Diez, E. R. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0842-6 · Cited by 87
Faulkner, J., Kennard, S., Huby, A.-C., Antonova, G. N., Lu, Q. R., Jaffe, I. Z., Patel, V. S., Fulton, D. J., & de Chantemèle, E. J. B. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.12802 · Cited by 84
Mineralocorticoid Receptors in Metabolic Syndrome: From Physiology to Disease
Feraco, A., Marzolla, V., Scuteri, A., Armani, A., & Caprio, M. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.11.006 · Cited by 83
The regulation of aldosterone secretion by leptin
Faulkner, J., Bruder-Nascimento, T. B., & de Chantemèle, E. J. B. (2017) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000384 · Cited by 85
Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism
Ohno, Y., Sone, M., Inagaki, N., Yamasaki, T., Ogawa, O., Takeda, Y., Kurihara, I., Umakoshi, H., Ichijo, T., Katabami, T., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00866 · Cited by 75
Weight Loss Medications in the Treatment of Obesity and Hypertension
Cohen, J. B., & Gadde, K. M. (2019) · Current Hypertension Reports · doi:10.1007/s11906-019-0915-1 · Cited by 81
Kawabe, Y., Mori, J., Morimoto, H., Yamaguchi, M., Miyagaki, S., Ota, T., Tsuma, Y., Fukuhara, S., Nakajima, H., Oudit, G. Y., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00311.2019 · Cited by 74
FKBP51 and the molecular chaperoning of metabolism
Smedlund, K., Sánchez, E. R., & Hinds, T. D. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.08.003 · Cited by 75
Is Primary Aldosteronism Still Largely Unrecognized?
Buffolo, F., Monticone, S., Burrello, J., Tetti, M., Veglio, F., Williams, T. A., & Mulatero, P. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-119755 · Cited by 74
Kidney and epigenetic mechanisms of salt-sensitive hypertension
Kawarazaki, W., & Fujita, T. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00399-2 · Cited by 73
Aldosterone-Regulated Sodium Transport and Blood Pressure
Tsilosani, A., Gao, C., & Zhang, W. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.770375 · Cited by 77
How does obesity affect the endocrine system? A narrative review
Poddar, M., Chetty, Y., & Chetty, V. T. (2017) · Clinical Obesity · doi:10.1111/cob.12184 · Cited by 74
Obesity, hypertension and aldosterone: is leptin the link?
Xie, D., & Bollag, W. B. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0160 · Cited by 69
Jia, G., Aroor, A. R., & Sowers, J. R. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx097 · Cited by 70
Obesity-associated cardiovascular risk in women: hypertension and heart failure
Faulkner, J. (2021) · Clinical Science · doi:10.1042/cs20210384 · Cited by 71
Aldosterone and cardiovascular diseases
Parksook, W. W., & Williams, G. H. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac027 · Cited by 69
The Effect of Aldosterone on Cardiorenal and Metabolic Systems
Otsuka, H., Abe, M., & Kobayashi, H. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065370 · Cited by 72
Aging and Adrenal Aldosterone Production
Nanba, K., Vaidya, A., & Rainey, W. E. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.10391 · Cited by 69
The Role of Aldosterone in OSA and OSA-Related Hypertension
Wang, Y., Li, C. X., Lin, Y. N., Zhang, L. Y., Li, S. Q., Zhang, L., Yan, Y. R., Lu, F., Li, N., & Li, Q. Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.801689 · Cited by 65
Salvatore, T., Galiero, R., Caturano, A., Vetrano, E., Rinaldi, L., Coviello, F., Di Martino, A., Albanese, G., Colantuoni, S., Medicamento, G., et al. (2022) · Biomolecules · doi:10.3390/biom12020176 · Cited by 62
Female Sex, a Major Risk Factor for Salt-Sensitive Hypertension
Faulkner, J., & de Chantemèle, E. J. B. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-01113-6 · Cited by 61
Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease
Huston, J., & Shah, S. J. (2022) · Circulation Research · doi:10.1161/circresaha.122.319967 · Cited by 61
Aldosterone Production and Signaling Dysregulation in Obesity
Vecchiola, A., Lagos, C. F., Carvajal, C. A., Baudrand, R. F., & Fardella, C. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0626-9 · Cited by 61
Packer, M. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1167 · Cited by 61
JAK/STAT3 signaling in cardiac fibrosis: a promising therapeutic target
Jiang, H., Yang, J., Li, T., Wang, X., Fan, Z., Ye, Q., & Du, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1336102 · Cited by 63
Faulkner, J., Harwood, D., Bender, L., Shrestha, L., Brands, M. W., Morwitzer, M. J., Kennard, S., Antonova, G. N., & de Chantemèle, E. J. B. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11303 · Cited by 58
Hypertensive Heart Disease and Obesity
Saliba, L. J., & Maffett, S. (2019) · Heart Failure Clinics · doi:10.1016/j.hfc.2019.06.003 · Cited by 58
The Vascular Involvement in Soft Tissue Fibrosis—Lessons Learned from Pathological Scarring
Huang, C., & Ogawa, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072542 · Cited by 58
Pathophysiology and genetics of salt-sensitive hypertension
Maaliki, D. S., Itani, M. M., & Itani, H. A. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1001434 · Cited by 61
Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant Hypertension
Dudenbostel, T., Ghazi, L., Liu, M., Li, P., Oparil, S., & Calhoun, D. A. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07806 · Cited by 58
Patel, R. B., Colangelo, L. A., Bielinski, S. J., Larson, N. B., Ding, J., Allen, N. B., Michos, E. D., Shah, S. J., & Lloyd‐Jones, D. M. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.019390 · Cited by 56
Mechano-energetic uncoupling in heart failure
Aksentijević, D., Sedej, S., Fauconnier, J., Paillard, M., Abdellatif, M., Streckfuß‐Bömeke, K., Ventura‐Clapier, R., van der Velden, J., de Boer, R. A., Bertero, E., et al. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01167-6 · Cited by 55
Foxc2 coordinates inflammation and browning of white adipose by leptin-STAT3-PRDM16 signal in mice
Gan, L., Liu, Z.-J., Feng, F., Wu, T., Luo, D., Hu, C., & Sun, C. (2018) · International Journal of Obesity · doi:10.1038/ijo.2017.208 · Cited by 46
Impact of Adrenal Steroids on Regulation of Adipose Tissue
Infante, M., Armani, A., Mammi, C., Fabbri, A., & Caprio, M. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160037 · Cited by 58
Linking Arrhythmias and Adipocytes: Insights, Mechanisms, and Future Directions
Pabón, M. A., Manocha, K. K., Cheung, J. W., & Lo, J. C. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01752 · Cited by 48
Ghafar, M. T. A. (2020) · Steroids · doi:10.1016/j.steroids.2020.108701 · Cited by 53
Cardiopulmonary Dysfunction and Adiponectin in Adolescents With Type 2 Diabetes
Bjornstad, P., Truong, U. T., Dorosz, J. L., Cree‐Green, M., Baumgartner, A., Coe, G. V., Pyle, L., Regensteiner, J. G., Reusch, J. E. B., & Nadeau, K. J. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002804 · Cited by 47
(2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.07.012 · Cited by 46
Links between aldosterone excess and metabolic complications: A comprehensive review
Bothou, C., Beuschlein, F., & Spyroglou, A. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.02.003 · Cited by 52
Kobayashi, M., Pitt, B., Ferreira, J. P., Rossignol, P., Girerd, N., & Zannad, F. M. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf225 · Cited by 51
Evaluation of the pathophysiological mechanisms of salt-sensitive hypertension
Hirohama, D., & Fujita, T. (2019) · Hypertension Research · doi:10.1038/s41440-019-0332-5 · Cited by 43
Wiegel, R. E., Danser, A. H. J., Steegers‐Theunissen, R. P. M., Laven, J. S. E., Willemsen, S. P., Baker, V. L., Steegers, E. A. P., & von Versen‐Höynck, F. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa582 · Cited by 44
Jia, G., Lockette, W. E., & Sowers, J. R. (2021) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00280.2020 · Cited by 47
Obesity: The Perfect Storm for Heart Failure
Lembo, M., Strisciuglio, T., Fonderico, C., Mancusi, C., Izzo, R., Trimarco, V., Bellis, A., Barbato, E., Esposito, G., Morisco, C., et al. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14641 · Cited by 51
Sex differences in sympathetic activity in obesity and its related hypertension
Fu, Q. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14095 · Cited by 42
Hu, Y., Zhang, J., Liu, W., & Su, X. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz293 · Cited by 43
The Mineralocorticoid Receptor in Salt-Sensitive Hypertension and Renal Injury
Ayuzawa, N., & Fujita, T. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020071041 · Cited by 42
Chen, J., Mei, Z., Yang, Y., Dai, C., Wang, Y., Zeng, R., & Liu, Q. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02703-9 · Cited by 41
da Costa, R. M., Cerqueira, D. M., Bruder‐Nascimento, A., Alves, J. V., Awata, W. M. C., Singh, S., Kufner, A., Prado, D. D. S., Johny, E., Cifuentes-Pagano, E., et al. (2024) · Hypertension · doi:10.1161/hypertensionaha.123.21888 · Cited by 41
Normotension, hypertension and body fluid regulation: brain and kidney
Bie, P., & Evans, R. G. (2016) · Acta Physiologica · doi:10.1111/apha.12718 · Cited by 39
Mechanisms of leptin-induced endothelial dysfunction
Mellott, E., & Faulkner, J. (2022) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000867 · Cited by 41
Crum, Y., Hoendermis, E. S., van Veldhuisen, D. J., van Woerden, G., Lobeek, M., Dickinson, M. G., Meems, L. M. G., Voors, A. A., Rienstra, M., & Gorter, T. M. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14739 · Cited by 39
The endothelial mineralocorticoid receptor
Davel, A. P., Anwar, I. J., & Jaffe, I. Z. (2016) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000306 · Cited by 39
Gan, L., Liu, Z., Luo, D., Ren, Q., Wu, H., Li, C., & Sun, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01507 · Cited by 38
Gutiérrez-Tenorio, J., Marín‐Royo, G., Martínez‐Martínez, E., Martín, R., Miana, M., López‐Andrés, N., Jurado-López, R., Gallardo, I., Luaces, M., Román, J. A. S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17103-9 · Cited by 38
Davel, A. P., Jaffe, I. Z., Tostes, R. C., Jaisser, F., & de Chantemèle, E. J. B. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00073.2018 · Cited by 39
Li, M., Cui, M., Li, G., Liu, Y., Xu, Y., Eftekhar, S. P., & Ala, M. (2024) · Hormone and Metabolic Research · doi:10.1055/a-2266-1503 · Cited by 37
Tao, Z., Zuo, P., & Ma, G. (2024) · Scientific Reports · doi:10.1038/s41598-024-69486-1 · Cited by 37
Metadata
- Authors
- Huby, A.-C., Antonova, G., Groenendyk, J., Gomez-Sanchez, C. E., Bollag, W. B., Filosa, J. A., & de Chantemèle, E. J. B.
- Affiliations
- Augusta University (US)
- From Physiology Department, Medical College of Georgia at Georgia Regents University, Augusta (A.-C.H., G.A., J.G., W.B.B., J.A.F., E.J.D.d.C.); Charlie Norwood VA Medical Center, Augusta, GA (W.B.B.); Endocrine Section, G.V. (Sonny) Montgomery VA Medical Center, and University of Mississippi Medical Center, Jackson (C..E.G.-S.).
- Venue
- Circulation
- Published
- 2015-12
- Volume
- 132
- Issue
- 22
- Pages
- 2134-2145
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2206025985
- Cited by
- 376
- References
- 49
- Citations by year
- 2026: 34 · 2025: 41 · 2024: 37 · 2023: 34 · 2022: 44 · 2021: 32 · 2020: 36 · 2019: 31 · 2018: 37 · 2017: 29 · 2016: 18 · 2015: 1
- FWCI
- 24.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- leptin, aldosterone secretion, CYP11B2, aldosterone synthase, obesity, hyperaldosteronism, adrenal glomerulosa cells, adipokines, endothelial dysfunction, myocardial fibrosis, calcium signaling, calcium/calmodulin-dependent protein kinase II, mineralocorticoid receptor, cardiovascular disease
- MeSH terms
- Adrenal Cortex, Aldosterone, Animals, Cells, Cultured, Endothelium, Vascular, Female, Fibrosis, Heart Diseases, Humans, Mice, Inbred C57BL, Mice, Obese, Rats, Inbred WKY, Rats, Zucker, Adipocytes, Mice, Knockout, Leptin, Cell Line, Tumor, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review